Ginkgo Bioworks Holdings (DNA) Acquisitions (2021 - 2024)
Ginkgo Bioworks Holdings' (DNA) quarterly Acquisitions came in at $5.4 million in Q1 2024, up 157.8% quarter-over-quarter from -$9.3 million in Q4 2021.
Powered by 
Analysis
Ginkgo Bioworks Holdings (DNA) Acquisitions (2021 - 2024) Analysis & Trends
Ginkgo Bioworks Holdings (DNA) has reported Acquisitions for 2 consecutive years, with $5.4 million the latest figure, recorded in Q1 2024.
- For the quarter ending Q1 2024, Acquisitions changed N/A year-over-year to $5.4 million; the trailing twelve-month figure through Dec 2024 stood at $5.4 million (changed N/A YoY), and the FY2024 full-year result was $5.4 million, changed N/A from the prior year.
- Acquisitions climbed to $5.4 million in Q1 2024 per DNA's latest filing, from -$9.3 million in the prior quarter.
- Across five years, Acquisitions topped out at $20.2 million in Q3 2021 and bottomed at -$9.3 million in Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 163.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | - |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | - |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 62.25 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 5.47 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 5.40 Mn |
| Dec 31, 2021 | -9.34 Mn |
| Sep 30, 2021 | 20.17 Mn |
| Mar 31, 2021 | 1.21 Mn |